European Journal of Molecular Pharmacy

Relating Molecular Insight to Pharmaceutical Advancement

The European Journal of Molecular Pharmacy (EJMP) promotes research that bridges molecular insights with practical pharmaceutical applications. The journal welcomes studies that:

• Investigate drug action and molecular response mechanisms.
• Develop innovative drug delivery systems and formulations.
• Explore pharmacodynamics, pharmacokinetics, and therapeutic optimization.
• Translate molecular research into clinical and preclinical applications.
• Enhance the safety and efficacy of pharmaceutical solutions.

Areas of Interest

The European Journal of Molecular Pharmacy (EJMP) publishes original research articles and authoritative reviews across a broad spectrum of molecular and pharmaceutical sciences. Key areas include:

• Molecular pharmacology and drug–target interactions
• Pharmaceutical biotechnology and biopharmaceutics
• Nanotechnology and targeted drug delivery systems
• Medicinal chemistry and rational drug design
• Pharmacogenomics and personalized therapeutics
• Formulation science, excipient development, and drug stability

EJMP also welcomes multidisciplinary studies that bridge molecular discoveries with innovative pharmaceutical technologies and clinical applications.

Peer Review and Publication Ethics

All manuscripts submitted to the European Journal of Molecular Pharmacy (EJMP) undergo a rigorous double-blind peer-review process, ensuring that both authors and reviewers remain anonymous throughout the evaluation. This approach promotes impartiality, fairness, and objectivity in the review process.

Each submission is evaluated by independent experts in the relevant field to ensure high standards of scientific quality, originality, and integrity. EJMP is committed to transparent editorial practices and adheres to internationally recognized ethical guidelines in scholarly publishing, maintaining trust and credibility in all published research.

The journal is committed to maintaining transparency in editorial decisions and strictly adheres to established COPE guidelines in scholarly publishing, ensuring credibility and trust in the dissemination of research.

Open Access Policy

EJMP operates under a full open-access model, providing immediate and unrestricted access to all published content. This approach promotes global visibility, enhances knowledge exchange, and supports collaboration among researchers, clinicians, and industry professionals worldwide.

All articles are freely accessible, enabling the wider scientific community to read, share, and build upon published work without barriers.